Pre-exposure prophylaxis (PrEP) was subsidised by the Australian Pharmaceutical Benefits Scheme (PBS) in April 2018. GPs and HIV/sexual health specialists are key actors in prescribing PrEP to get maximal coverage of populations at risk of acquiring HIV, particularly gay and bisexual men. However, little research has been conducted in Australia to explore the various factors which shape the context and experience of prescribing PrEP.

In this qualitative study, we examined clinician perspectives on prescribing PrEP in Australia, recruiting participants from New South Wales and Western Australia. The primary aim of this study was to understand the effects of PrEP on clinical practice in a time of rapid change. The study has deepened our understanding of how clinicians engage with new areas of practice and negotiate new technologies, clinical guidelines, uncertainty, risk and the complex lives of patients. See for more information, or email the project manager, Anthony K J Smith.

Research Centre

Centre for Social Research in Health

Research Area

HIV and Sexual Health | Sexuality, Health and Education

Smith, A. K. J., Newman, C. E., Haire, B., & Holt, M. (2021). Clinician imaginaries of HIV PrEP users in and beyond the gay community in Australia. Culture, Health & Sexuality.

Smith, A. K. J., Holt, M., Haire, B. & Newman, C. (2021). Issues associated with prescribing HIV pre-exposure prophylaxis (PrEP) for HIV anxiety: a qualitative analysis of Australian PrEP providers’ views. Journal of the Association of Nurses in AIDS Care, 32(1), 94-104.

Smith, A. K. J., Haire, B., Newman, C., & Holt, M. (2021). Challenges of providing PrEP across Australian clinics: qualitative insights of clinicians. Sexual Health, 18(2), 187-94.

Bridget Haire, The Kirby Institute

Related people